1)Brandt CM, Spellerberg B : Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis 49:766-772,2009
2)Zurawski CA, Bardsley M, Beall B, et al : Invasive group A streptococcal disease in metropolitan Atlanta : a population-based assessment. Clin Infect Dis 27:150-157,1998
3)Davies HD, McGeer A, Schwartz B, et al : Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 335:547-554,1996
4)厚生労働省院内感染対策事業(JANIS):公開情報2019年1月〜12月年報(全集計対象医療機関)院内感染対策サーベイランス検査部門【入院検体】(https://janis.mhlw.go.jp/report/open_report/2019/3/1/ken_Open_Report_201900.pdf)(2020年12月28日アクセス)
5)Kim S, Byun JH, Park H, et al : Molecular Epidemiological Features and Antibiotic Susceptibility Patterns of Streptococcus dysgalactiae subsp. equisimilis Isolates from Korea and Japan. Ann Lab Med 38:212-219,2018
6)Leitner E, Zollner-Schwetz I, Zarfel G, et al : Prevalence of emm types and antimicrobial susceptibility of Streptococcus dysgalactiae subsp. equisimilis in Austria. Int J Med Microbiol 305:918-924,2015